Aspillaga, M. O., Whittaker, P. G., Grey, C. E., & Lind, T. (1983). Endocrinologic events in early pregnancy failure. American Journal of Obstetrics and Gynecology, 147(8), 903-908. https://doi.org/10.1016/0002-9378(83)90243-0
Aspillaga MO, Whittaker PG, Grey CE, Lind T. Endocrinologic events in early pregnancy failure. Am J Obstet Gynecol. 1983;147(8):903-908. doi:10.1016/0002-9378(83)90243-0
Aspillaga, Margaret O., et al. "Endocrinologic events in early pregnancy failure." American Journal of Obstetrics and Gynecology, vol. 147, no. 8, 1983, pp. 903-908.
Fourteen women experiencing early pregnancy failure have been studied during the time of conception and at frequent intervals until spontaneous abortion occurred. Serial measurements of serum estradiol, progesterone, 17 alpha-hydroxyprogesterone, prolactin, human placental lactogen (hPL), and human chorionic gonadotropin (hCG) were determined; regular sonar scanning allowed the time of fetal death to be determined to within 7 days in six patients and a diagnosis of blighted ovum to be made in the remainder. In all patients serum progesterone and estradiol concentrations were within the normal range up to 7 weeks but appeared to decrease from about 8 weeks' gestation whether or not a living fetus was present. The placenta continued to produce hCG and hPL but, despite the continuing presence of hCG, the levels of 17 alpha-hydroxyprogesterone declined to concentrations below those associated with normal pregnancy. These data suggest that the placenta may require a particular stimulus to take over production of progesterone and estradiol.
Miscarriage affects approximately 15% of clinically confirmed pregnancies. Recurrent pregnancy loss (RPL), defined as two or more clinical losses, affects 2 to 5% of couples. Most causes are diagnosable and treatable. This guide covers what the standard workup misses, what RRM-trained clinicians evaluate, and what outcomes look like after cause-based treatment.